Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT06717932
A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection
Sponsor: CorrectSequence Therapeutics Co., Ltd
View on ClinicalTrials.gov
Summary
This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-01 (NCT06291961),No investigational drug product will be administered in the study.
Official title: A Long-term Follow-up Study Evaluating the Safety and Efficacy of Subjects With β-thalassemia Treated With CS-101 Transplantation
Key Details
Gender
All
Age Range
12 Years - 35 Years
Study Type
OBSERVATIONAL
Enrollment
8
Start Date
2025-05-15
Completion Date
2039-11
Last Updated
2026-02-10
Healthy Volunteers
No
Conditions
Locations (1)
The First Affiliated Hospital of Guangxi Medical University
Nanning, China